Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 14;12(10):1715.
doi: 10.3390/jpm12101715.

Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005-2012 Study

Po-Cheng Su  1 , Cai-Mei Zheng  1   2   3 , Chien-Chou Chen  4 , Li-Yun Chiu  1   5 , Hao-Yun Chang  1   6 , Meng-Hsu Tsai  1 , Chia-Te Liao  1   2   3 , Chih-Chin Kao  1   2   7 , Yung-Ho Hsu  1   2   3 , Che-Chou Shen  8 , Chih-Cheng Hsu  9 , Mai-Szu Wu  1   2   3 , Yen-Chung Lin  1   2   7
Affiliations

Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005-2012 Study

Po-Cheng Su et al. J Pers Med. .

Abstract

Introduction: End-stage kidney disease (ESKD) patients who need renal replacement therapy need to face a dialysis modality decision: the choice between hemodialysis (HD) and peritoneal dialysis (PD). Although the global differences in HD/PD penetration are affected by health-care policies, these two modalities may exert different effects on survival in patients with ESKD. Although Taiwan did not implicate PD as first policy, we still need to compare patients’ outcomes using two modalities in a nation-wise database to determine future patients’ care and health policies. Methods: We used the nationwide Taiwan Renal Registry Data System (TWRDS) database from 2005 to 2012 and included 52,900 patients (48,371 on HD and 4529 on PD) to determine all-cause and cardiovascular mortality among ESKD patients. Results: Age-matched survival probability from all-cause mortality was significantly lower in patients on PD than in those on HD (p < 0.05). The adjusted hazard ratios of 3-year and 5-year all-cause and cardiovascular mortality were significantly higher in PD compared with HD. The presence of comorbid conditions including myocardial infarction, coronary artery disease (CAD), diabetes mellitus (DM), hypoalbuminemia, hyperferritinemia and hypophosphatemia was related with significantly higher all-cause and CV mortality in PD patients. No significant difference was noted among younger patients <45 years of age regardless of DM and/or comorbid conditions. Conclusion: Although PD did not have the survival advantage compared to HD in all dialysis populations, PD was related with superior survival in younger non-DM patients, regardless of the presence of comorbidities. Similarly, for younger ESKD patients without the risk of CV disease, both PD and HD would be suitable dialysis modalities.

Keywords: end-stage kidney disease; hemodialysis; mortality; peritoneal dialysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the whole population (N = 52,900).
Figure 2
Figure 2
Survival curves between all-death survival (A) and CV-death survival (B).
Figure 3
Figure 3
Age-matched survival curves between all-death survival (A) and CV-death survival (B).
See this image and copyright information in PMC

References

    1. Selby N.M., Kazmi I. Peritoneal dialysis has optimal intradialytic hemodynamics and preserves residual renal function: Why isn’t it better than hemodialysis? Semin. Dial. 2019;32:3–8. doi: 10.1111/sdi.12752. - DOI - PubMed
    1. Van De Luijtgaarden M.W., Jager K.J., Stel V.S., Kramer A., Cusumano A., Elliott R.F., Geue C., MacLeod A.M., Stengel B., Covic A., et al. Global differences in dialysis modality mix: The role of patient characteristics, macroeconomics and renal service indicators. Nephrol. Dial. Transplant. 2013;28:1264–1275. doi: 10.1093/ndt/gft053. - DOI - PubMed
    1. Jansen M.A., Hart A.A., Korevaar J.C., Dekker F.W., Boeschoten E.W., Krediet R.T. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046–1053. doi: 10.1046/j.1523-1755.2002.00505.x. - DOI - PubMed
    1. Polinder-Bos H.A., García D.V., Kuipers J., Elting J.W.J., Aries M.J., Krijnen W.P., Groen H., Willemsen A.T., Van Laar P.J., Strijkert F., et al. Hemodialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients. J. Am. Soc. Nephrol. 2018;29:1317–1325. doi: 10.1681/ASN.2017101088. - DOI - PMC - PubMed
    1. Nakayama M., Kawaguchi Y., Yamada K., Hasegawa T., Takazoe K., Katoh N., Hayakawa H., Osaka N., Yamamoto H., Ogawa A., et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997;51:182–186. doi: 10.1038/ki.1997.22. - DOI - PubMed

LinkOut - more resources